Idexx Laboratories Inc IDXX reported a better-than-expected first-quarter profit and lifted its target for the full year.
Idexx Laboratories' quarterly earnings surged to $40.7 million, or $0.72 per share, versus $36.6 million, or $0.62 per share, in the year-ago period. Its revenue climbed 10% to $322.7 million. Revenue at its companion animal group business surged 10%.
Analysts were expecting earnings of $0.71 per share on revenue of $314.2 million.
Idexx Laboratories expects 2012 earnings of $3.07 to $3.12 per share, on revenue of $1.31 billion to $1.32 billion. However, analysts were projecting earnings of $3.07 per share on revenue of $1.30 billion.
Idexx Laboratories shares closed at $88.18 yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in